Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-01

FDA Approved: GABAPENTIN — Original Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original ANDA for gabapentin from XLCare Pharmaceuticals, enabling a generic version of the anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)